Recent advances in radiation therapy

American Family Physician

Volumn 78, Issue 11, 2008, Pages

  Gerber, David E ^a,c   Chan, Timothy A ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA TOCOPHEROL; ANALGESIC AGENT; ANTIEMETIC AGENT; CORTICOSTEROID; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; IODINE 131; LIDOCAINE; LOPERAMIDE; PENTOXIFYLLINE; PILOCARPINE; SAMARIUM 153; SILDENAFIL; STRONTIUM 89; TAMSULOSIN; THYROID HORMONE;

ACOUSTIC NEURINOMA; ALOPECIA; AMNESIA; ANAPHYLAXIS; ANUS CANCER; ARTHROPATHY; BILE DUCT OBSTRUCTION; BLADDER CANCER; BLADDER SPASM; BLINDNESS; BONE MARROW SUPPRESSION; BONE METASTASIS; BONE NECROSIS; BONE PAIN; BRACHYTHERAPY; BRAIN EDEMA; BREAST CANCER; BRONCHUS OBSTRUCTION; CANCER PATIENT; CANCER RADIOTHERAPY; CATARACT; COLON CANCER; CORONARY ARTERY DISEASE; CORONARY STENT; CYBERKNIFE; CYSTITIS; DENTAL CARIES; DIARRHEA; DYSPHAGIA; ENDOMETRIUM CANCER; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS STRICTURE; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FOLLOW UP; GLIOBLASTOMA; HEART SURGERY; HUMAN; HYPERBARIC OXYGEN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMPOTENCE; INFERTILITY; INTENSITY MODULATED RADIATION THERAPY; KIDNEY FAILURE; KIDNEY TUMOR; LARYNX CANCER; LIVER INJURY; LIVER TUMOR; LUNG CANCER; LUNG DISEASE; LUNG FIBROSIS; LUNG TUMOR; LYMPHEDEMA; MALE GENITAL SYSTEM SURGERY; MENINGIOMA; MOTOR DYSFUNCTION; MUCOSA INFLAMMATION; MUSCLE EXERCISE; MYELITIS; NAUSEA; OPTIC NEURITIS; OROPHARYNX CANCER; OXYGEN THERAPY; PANCREAS CANCER; PANCREAS TUMOR; PARALYSIS; PATIENT CARE; PERICARDITIS; PHYSICIAN; PHYSIOTHERAPY; PNEUMONIA; PROCTITIS; PROSTATE CANCER; PROSTATE TUMOR; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INDUCED EMESIS; RADIATION INJURY; RADIATION NECROSIS; RADIOIMMUNOTHERAPY; RECTUM CANCER; RECTUM HEMORRHAGE; RETINA MACULA DEGENERATION; REVIEW; SARCOMA; SCAR FORMATION; SEMINOMA; SKIN CANCER; SMALL INTESTINE OBSTRUCTION; SPEECH DISORDER; SPEECH THERAPY; SPINE TUMOR; STEREOTACTIC RADIOSURGERY; STEREOTACTIC TREATMENT; STOMACH CANCER; STOMACH ULCER; STROKE; THYROID CANCER; TOOTH INFECTION; URETHRA STRICTURE; URINARY DYSFUNCTION; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE; UTERINE CERVIX CANCER; VAGINA DISEASE; VAGINAL DRYNESS; XEROSTOMIA; COMPUTER ASSISTED RADIOTHERAPY; METHODOLOGY; NEOPLASM; RADIATION RESPONSE; RADIOSURGERY;

BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NEOPLASMS; RADIOIMMUNOTHERAPY; RADIOSURGERY; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 58149355456     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst. 1996;88(13):890-899. (Pubitemid 26230640)
2. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091-2098. (Pubitemid 37464533)
3. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227-1232. (Pubitemid 35176241)
4. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-1241. (Pubitemid 35176242)
5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Breast cancer. 2008. http://www.nccn.org/professionals/physician- gls/PDF/breast.pdf. Accessed October 10, 2008.
6. Coutard H. Principles of x-ray therapy of malignant diseases. Lancet. 1934;2:1-8.
7. Perez CA, Hanks GE, Leibel SA, Zietman AL, Fuks Z, Lee WR. Localized carcinoma of the prostate. Review of management with external beam radiation therapy. Cancer. 1993;72(11):3156-3173.
8. Hamilton AS, Stanford JL, Gilliland FD, et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol. 2001;19(9):2517-2526.
9. Halperin EC, Schmidt-Ullrich RK, Perez CA. Overview and basic science of radiation oncology. In: Perez CA. Principles and Practices of Radiation Oncology. 4th ed. Philadelphia, Pa.: Lippincott Williams & WIlkins; 2004:1-95.
10. de Crevoisier R, Tucker SL, Don L, et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62(4):965-973. (Pubitemid 40884405)
11. Zelefsky MJ, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol. 2000;55(3):241-249. (Pubitemid 30408370)
12. Xia P, Pickett B, Vigneault E, Verhey LJ, Roach M III. Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy. Int J Radiat Oncol Biol Phys. 2001;51(1):244-254. (Pubitemid 32758884)
13. Daly ME, Lieskovsky Y, Pawlicki T, et al. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck. 2007;29(3):211-220. (Pubitemid 46339317)
14. Soffen EM, Hanks GE, Hunt MA, Epstein BE. Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques. Int J Radiat Oncol Biol Phys. 1992;24(3):485-488.
15. Shirato H, Shimizu S, Kunieda T, et al. Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48(4):1187-1195. (Pubitemid 30802157)
16. Vedam SS, Keall PJ, Kini VR, Mohan R. Determining parameters for respiration-gated radiotherapy. Med Phys. 2001;28(10):2139-2146. (Pubitemid 32977560)
17. Rades D, Bohlen G, Pluemer A, et al. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer. 2007;109(12):2515-2521. (Pubitemid 46906471)
18. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. JAMA. 2006;295(21):2483-2491. (Pubitemid 43854963)
19. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases. Lancet. 2004;363(9422):1665-1672.
20. Maruyama K, Kawahara N, Shin M, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005;352(2):146-153. (Pubitemid 40096611)
21. Régis J, Metellus P, Hayashi M, Roussel P, Donnet A, Bille-Turc F. Prospective controlled trial of Gamma Knife surgery for essential trigeminal neuralgia. J Neurosurg. 2006;104(6):913-924. (Pubitemid 43824741)
22. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007;25(8):947-952. (Pubitemid 350002860)
23. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24(30):4833-4839. (Pubitemid 46630909)
24. Vicini F, Beitsch PD, Quiet CA, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer. 2008;112(4):758-766. (Pubitemid 351240569)
25. Chan TA, Weingart JD, Parisi M, et al. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Int J Radiat Oncol Biol Phys. 2005;62(4):1133-1139. (Pubitemid 40884428)
26. Jonklaas J, Sarlis NJ, Litofsky D, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid. 2006;16(12):1229-1242. (Pubitemid 46080167)
27. Bauman G, Charette M, Reid R, Sathya J. Radiopharmaceuticals for the palliation of painful bone metastasis. Radiother Oncol. 2005;75(3):258-270.
28. Crook JM, Choan E, Perry GA, Robertson S, Esche BA. Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure. Urology. 1998;51(4):566-572. (Pubitemid 28186208)
29. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Comparative effectiveness and harms of treatments for clinically localized prostate cancer [published correction appears in Ann Intern Med. 2008;148(11):888]. Ann Intern Med. 2008;148(6):435-448. (Pubitemid 351665443)
30. Paulson DF, Lin GH, Hinshaw W, Stephani S. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol. 1982;128(3):502-504. (Pubitemid 12037692)
31. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Prostate cancer. 2008. http://www.nccn.org/professionals/physician- gls/PDF/prostate.pdf. Accessed October 10, 2008.
32. Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol. 2007;2(7 suppl 3):S101-112. (Pubitemid 47183603)
33. Konski A, Watkins-Bruner D, Feigenberg S, et al. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. Int J Radiat Oncol Biol Phys. 2006;66(2):408-415. (Pubitemid 44332736)
34. Konski A, Sherman E, Krahn M, et al. Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys. 2005;63(3):788-794.
35. American Society for Therapeutic Radiology and Oncology. Fast facts about radiation oncology. http://www.astro.org/PressRoom/FastFacts/documents/FFRT121. pdf. Accessed August 14, 2008.
36. Gunderson LL, Tepper JE. Clinical Radiation Oncology. Philadelphia, Pa.: Elsevier; 2007:1-74.
37. National Cancer Institute. Radiation therapy and you. http://www.can cer.gov/cancertopics/radiation-therapy-and-you. Accessed August 13, 2008.
38. Hensley ML, Schuchter LM Lindley C, et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol. 1999;17(10):3333-3355. (Pubitemid 29471562)
39. Keefe DM, Schubert MM, Elting LS, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007;109(5):820-831. (Pubitemid 46335677)
40. Small W Jr, Woloschak GE. Radiation Toxicity. New York, NY: Springer; 2006.
41. Bolderston A, Lloyd NS, Wong RK, Holden L, Robb-Blenderman L. The prevention and management of acute skin reactions related to radiation therapy. Support Care Cancer. 2006;14(8):802-817.
42. Pereg D, Koren G, Lishner M. Cancer in pregnancy. Cancer Treat Rev. 2008;34(4):302-312.